Your browser doesn't support javascript.
loading
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity.
Wang, David; Quiros, Jason; Mahuron, Kelly; Pai, Chien-Chun; Ranzani, Valeria; Young, Arabella; Silveria, Stephanie; Harwin, Tory; Abnousian, Arbi; Pagani, Massimiliano; Rosenblum, Michael D; Van Gool, Frederic; Fong, Lawrence; Bluestone, Jeffrey A; DuPage, Michel.
Afiliación
  • Wang D; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Division of Pediatric Hematology and Oncology, University of California, San Francisco Benioff Children's Hospital, San Francisco, CA 94158, USA.
  • Quiros J; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Mahuron K; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Pai CC; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Ranzani V; Istituto Nazionale Genetica Molecolare (INGM) "Romeo ed Enrica Invernizzi," Milan 20122, Italy.
  • Young A; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Silveria S; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Harwin T; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
  • Abnousian A; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
  • Pagani M; Istituto Nazionale Genetica Molecolare (INGM) "Romeo ed Enrica Invernizzi," Milan 20122, Italy; Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano 20129, Italy.
  • Rosenblum MD; Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Van Gool F; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Fong L; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.
  • Bluestone JA; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA. Electronic address: jeff.bluestone@ucsf.edu.
  • DuPage M; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA; Department of Molecular a
Cell Rep ; 23(11): 3262-3274, 2018 06 12.
Article en En | MEDLINE | ID: mdl-29898397
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Proteína Potenciadora del Homólogo Zeste 2 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Proteína Potenciadora del Homólogo Zeste 2 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos